John R. Jack, Ph.D. - Publications

Affiliations: 
2009 Louisiana Tech University, Ruston, LA, United States 
Area:
Computer Science, Bioinformatics Biology

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Roell KR, Havener TM, Reif DM, Jack J, McLeod HL, Wiltshire T, Motsinger-Reif AA. Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines. Frontiers in Genetics. 10: 829. PMID 31681399 DOI: 10.3389/Fgene.2019.00829  0.386
2018 Akhtari FS, Havener TM, Fukudo M, Jack JR, McLeod HL, Wiltshire T, Motsinger-Reif AA. The influence of Neanderthal alleles on cytotoxic response. Peerj. 6: e5691. PMID 30386687 DOI: 10.7717/Peerj.5691  0.42
2018 Rotroff DM, Yee SW, Zhou K, Marvel SW, Shah HS, Jack JR, Havener TM, Hedderson MM, Kubo M, Herman MA, Gao H, Mychaleckyi JC, McLeod HL, Doria A, Giacomini KM, et al. Genetic Variants in and are Associated with Variation in Response to Metformin in Individuals with Type 2 Diabetes. Diabetes. PMID 29650774 DOI: 10.2337/Db17-1164  0.346
2017 Jack J, Small GW, Brown CC, Havener TM, McLeod HL, Motsinger-Reif AA, Richards KL. Gene expression and linkage analysis implicate CBLB as a mediator of rituximab resistance. The Pharmacogenomics Journal. PMID 29205205 DOI: 10.1038/Tpj.2017.41  0.379
2017 Rotroff DM, Pijut SS, Marvel SW, Jack JR, Havener TM, Pujol A, Schluter A, Graf GA, Ginsberg HN, Shah HS, Gao H, Morieri ML, Doria A, Mychaleckyi JC, McLeod HL, et al. Genetic variants in HSD17B3, SMAD3, and IPO11 impact circulating lipids in response to fenofibrate in individuals with type 2 diabetes. Clinical Pharmacology and Therapeutics. PMID 28736931 DOI: 10.1002/Cpt.798  0.347
2016 Jackson JN, Long KM, He Y, Motsinger-Reif AA, McLeod HL, Jack J. A comparison of DMET Plus microarray and genome-wide technologies by assessing population substructure. Pharmacogenetics and Genomics. PMID 26731477 DOI: 10.1097/Fpc.0000000000000200  0.352
2016 Jack J, Small G, Havener T, Brown C, McLeod H, Motsinger A, Richards KL. Abstract 1487: Gene expression and linkage analysis implicates CBLB as a mediator of rituximab resistance Cancer Research. 76: 1487-1487. DOI: 10.1158/1538-7445.Am2016-1487  0.328
2015 Jack J, Havener TM, McLeod HL, Motsinger-Reif AA, Foster M. Evaluating the role of admixture in cancer therapy via in vitro drug response and multivariate genome-wide associations. Pharmacogenomics. 16: 1451-63. PMID 26314407 DOI: 10.2217/Pgs.15.85  0.396
2015 Abdo N, Xia M, Brown CC, Kosyk O, Huang R, Sakamuru S, Zhou YH, Jack JR, Gallins P, Xia K, Li Y, Chiu WA, Motsinger-Reif AA, Austin CP, Tice RR, et al. Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study. Environmental Health Perspectives. 123: 458-66. PMID 25622337 DOI: 10.1289/Ehp.1408775  0.386
2015 Jack J, Havener TM, McLeod HL, Motsinger-Reif AA, Foster M. Abstract LB-246: Evaluating the role of admixture in cancer therapy via in vitro drug response and multivariate genome-wide associations Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-246  0.374
2014 Jack J, Rotroff D, Motsinger-Reif A. Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model. Current Molecular Medicine. 14: 833-40. PMID 25109794 DOI: 10.2174/1566524014666140811113946  0.445
2014 Che R, Jack JR, Motsinger-Reif AA, Brown CC. An adaptive permutation approach for genome-wide association study: evaluation and recommendations for use. Biodata Mining. 7: 9. PMID 24976866 DOI: 10.1186/1756-0381-7-9  0.332
2014 Huang W, Massouras A, Inoue Y, Peiffer J, Ràmia M, Tarone AM, Turlapati L, Zichner T, Zhu D, Lyman RF, Magwire MM, Blankenburg K, Carbone MA, Chang K, Ellis LL, ... ... Jack JR, et al. Natural variation in genome architecture among 205 Drosophila melanogaster Genetic Reference Panel lines. Genome Research. 24: 1193-208. PMID 24714809 DOI: 10.1101/Gr.171546.113  0.379
2014 Hertz DL, Roy S, Jack J, Motsinger-Reif AA, Drobish A, Clark LS, Carey LA, Dees EC, McLeod HL. Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy. Breast Cancer Research and Treatment. 145: 245-54. PMID 24706167 DOI: 10.1007/S10549-014-2910-1  0.354
2014 Brown CC, Havener TM, Medina MW, Jack JR, Krauss RM, McLeod HL, Motsinger-Reif AA. Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines. Pharmacogenomics. 15: 137-46. PMID 24444404 DOI: 10.2217/Pgs.13.213  0.363
2011 Jack J, Wambaugh JF, Shah I. Simulating quantitative cellular responses using asynchronous threshold Boolean network ensembles. Bmc Systems Biology. 5: 109. PMID 21745399 DOI: 10.1186/1752-0509-5-109  0.33
Show low-probability matches.